Sam Ghilardi 6/9/26 Sam Ghilardi 6/9/26

Another Watertown Biotech Goes Public and the Commonwealth Claws Back Hiring Tax Credits

Plus pre-clinical data results and more!

Sam Ghilardi 5/12/26 Sam Ghilardi 5/12/26

Kestrel's $1.45 billion AbbVie Deal, FDA Approves First Ever PROTAC, and Werewolf Breaks Arsenal Lease.

Plus more details on Windgap's big pharma partnership and a number of people moves.

Sam Ghilardi 5/5/26 Sam Ghilardi 5/5/26

Two big conferences last month generated a flurry of posters from Watertown biotechs

Sam Ghilardi 1/20/26 Sam Ghilardi 1/20/26

2025 Funding numbers are in, 2026 early raises, Lyra Therapeutics runs out of time and more

Sam Ghilardi 1/6/26 Sam Ghilardi 1/6/26

Neumora's positive clinical data , new tenants at the Arsenal, and more

Sam Ghilardi 12/16/25 Sam Ghilardi 12/16/25

A Multi-Million dollar public offering, the developing race for a dupilumab alternative, business awards, and more.